Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nele Plock

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Pharmacology Research & Perspectives|June 5, 2018
Pharmacokinetics and pharmacodynamics of the cytolytic anti-CD38 human monoclonal antibody TAK-079 in monkey - model assisted preparation for the first in human trialStefan Roepcke, Nele Plock, Josh Yuan, et al.
The Journal of Antimicrobial Chemotherapy|November 15, 2007
Effect of severity of sepsis on tissue concentrations of linezolidChristiane Thallinger, Cornelia Buerger, Nele Plock, et al.
Scandinavian Journal of Infectious Diseases|December 22, 2007
Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysisLars B Stolle, Nele Plock, Christian Joukhadar, et al.
Clinical Pharmacology and Therapeutics|January 27, 2026
Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term InfantsZiheng Hu, Farina Hellmann, Xiaowei Zang, et al.
Communications Medicine|April 16, 2025
Efficacy of monoclonal antibodies and maternal vaccination for prophylaxis of respiratory syncytial virus diseaseNele Plock, Jeffrey R Sachs, Xiaowei Zang, et al.
Neurology and Therapy|March 24, 2025
Population Pharmacokinetic Modeling of TV-46000, a Risperidone Long-Acting Subcutaneous Antipsychotic for the Treatment of Patients with SchizophreniaItay Perlstein, Avia Merenlender Wagner, Anna Elgart, et al.
Ebiomedicine|October 1, 2022
Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approachBhargava Kandala, Nele Plock, Akshita Chawla, et al.
British Journal of Clinical Pharmacology|September 29, 2016
The variability in beta-cell function in placebo-treated subjects with type 2 diabetes: application of the weight-HbA1c-insulin-glucose (WHIG) modelJanna K Duong, Willem de Winter, Steve Choy, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Pharmacokinetics of enfuvirtide in patients treated in typical routine clinical settingsHartmut Stocker, Charlotte Kloft, Nele Plock, et al.
Ebiomedicine|November 14, 2021
Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxisBrian M Maas, Jos Lommerse, Nele Plock, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Pharmacology Research & Perspectives|June 5, 2018
Pharmacokinetics and pharmacodynamics of the cytolytic anti-CD38 human monoclonal antibody TAK-079 in monkey - model assisted preparation for the first in human trialStefan Roepcke, Nele Plock, Josh Yuan, et al.
The Journal of Antimicrobial Chemotherapy|November 15, 2007
Effect of severity of sepsis on tissue concentrations of linezolidChristiane Thallinger, Cornelia Buerger, Nele Plock, et al.
Scandinavian Journal of Infectious Diseases|December 22, 2007
Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysisLars B Stolle, Nele Plock, Christian Joukhadar, et al.
Clinical Pharmacology and Therapeutics|January 27, 2026
Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term InfantsZiheng Hu, Farina Hellmann, Xiaowei Zang, et al.
Communications Medicine|April 16, 2025
Efficacy of monoclonal antibodies and maternal vaccination for prophylaxis of respiratory syncytial virus diseaseNele Plock, Jeffrey R Sachs, Xiaowei Zang, et al.
Neurology and Therapy|March 24, 2025
Population Pharmacokinetic Modeling of TV-46000, a Risperidone Long-Acting Subcutaneous Antipsychotic for the Treatment of Patients with SchizophreniaItay Perlstein, Avia Merenlender Wagner, Anna Elgart, et al.
Ebiomedicine|October 1, 2022
Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approachBhargava Kandala, Nele Plock, Akshita Chawla, et al.
British Journal of Clinical Pharmacology|September 29, 2016
The variability in beta-cell function in placebo-treated subjects with type 2 diabetes: application of the weight-HbA1c-insulin-glucose (WHIG) modelJanna K Duong, Willem de Winter, Steve Choy, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Pharmacokinetics of enfuvirtide in patients treated in typical routine clinical settingsHartmut Stocker, Charlotte Kloft, Nele Plock, et al.
Ebiomedicine|November 14, 2021
Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxisBrian M Maas, Jos Lommerse, Nele Plock, et al.
Pageof 2